Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Ascendis Pharma A/S changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 158 | 2 | 160 | +4 |
| Shares | 61.0M | 258.0K | 60.3M | −501.8K (−0.8%) |
| Value | $5.45B | $23.0M | $5.64B | +$219.9M (+4.1%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Ascendis Pharma A/S at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 170,870 | $16.0M | 0.02% |
| Balyasny Asset Management LLC | 94,868 | $8.88M | 0.02% |
| Millennium Management LLC | 42,852 | $4.01M | 0.00% |
| Voloridge Investment Management, LLC | 19,908 | $1.86M | 0.01% |
| First Republic Investment Management, Inc. | 19,325 | $1.81M | 0.01% |
| ExodusPoint Capital Management, LP | 13,743 | $1.29M | 0.02% |
| Capstone Investment Advisors, LLC | 3,672 | $343.8K | 0.01% |
| Tudor Investment Corp Et Al | 3,413 | $319.6K | 0.00% |
| Bayesian Capital Management, LP | 3,129 | $293.0K | 0.03% |
| Virtu Financial LLC | 2,995 | $280.0K | 0.03% |
| Group One Trading, L.P. | 2,844 | $266.3K | 0.01% |
| Gilbert & Cook, Inc. | 2,618 | $245.2K | 0.04% |
| Cresset Asset Management, LLC | 2,605 | $243.9K | 0.00% |
| Jefferies Financial Group Inc. | 2,500 | $234.1K | 0.01% |
| Legal & General Group Plc | 1,038 | $97.2K | 0.00% |
| Cullen/Frost Bankers, Inc. | 100 | $9.36K | 0.00% |
| Leonteq Securities AG | 48 | $4.50K | 0.00% |
| Parallel Advisors, LLC | 38 | $3.56K | 0.00% |
| Hoey Investments, Inc | 24 | $2.25K | 0.00% |
Sold out (15)
Institutions that held Ascendis Pharma A/S at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Renaissance Technologies LLC | 82,699 | $7.38M |
| Clough Capital Partners L P | 51,200 | $4.57M |
| State of Wisconsin Investment Board | 21,055 | $1.88M |
| Ergoteles LLC | 13,511 | $1.21M |
| Squarepoint Ops LLC | 11,125 | $992.9K |
| Alpha DNA Investment Management LLC | 8,601 | $767.6K |
| AE Wealth Management LLC | 5,923 | $528.6K |
| Mach-1 Financial Group, Inc. | 5,923 | $528.6K |
| Simplex Trading, LLC | 5,364 | $478.0K |
| Wolverine Trading, LLC | 3,857 | $337.5K |
| HRT Financial LP | 3,614 | $322.0K |
| Jump Financial, LLC | 2,400 | $214.2K |
| Ikarian Capital, LLC | 2,090 | $186.5K |
| Elequin Capital LP | 44 | $3.93K |
| Foster Dykema Cabot & Co Inc | 22 | $2.00K |
Not filed for Q3 2023 yet (2)
Institutions that held Ascendis Pharma A/S at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 138,791 | $12.4M |
| Pictet Asset Management SA | 119,258 | $10.6M |